Hyperphagia, lower body temperature, and reduced running wheel activity precede development of morbid obesity in New Zealand obese mice.
about
Genetic and epigenetic control of metabolic healthIdentification of Four Mouse Diabetes Candidate Genes Altering β-Cell ProliferationDo Dopaminergic Impairments Underlie Physical Inactivity in People with Obesity?Spontaneous voiding by mice reveals strain-specific lower urinary tract function to be a quantitative genetic traitAcutely decreased thermoregulatory energy expenditure or decreased activity energy expenditure both acutely reduce food intake in miceThe challenges for molecular nutrition research 2: quantification of the nutritional phenotype.Dissociation of lipotoxicity and glucotoxicity in a mouse model of obesity associated diabetes: role of forkhead box O1 (FOXO1) in glucose-induced beta cell failure.Mild calorie restriction induces fat accumulation in female C57BL/6J miceBiomarker discovery and redundancy reduction towards classification using a multi-factorial MALDI-TOF MS T2DM mouse model dataset.24-h core temperature in obese and lean men and women.PPINGUIN: Peptide Profiling Guided Identification of Proteins improves quantitation of iTRAQ ratiosThe genetic basis of obesity-associated type 2 diabetes (diabesity) in polygenic mouse modelsBiology of obesity: lessons from animal models of obesityAdipose hypothermia in obesity and its association with period homolog 1, insulin sensitivity, and inflammation in fat.Identification of a physiological role for leptin in the regulation of ambulatory activity and wheel running in miceCore body temperature in obesity.GLP-1-oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) miceLeptin: at the crossroads of energy balance and systemic inflammation.Role of Hypothalamic Creb-Binding Protein in Obesity and Molecular Reprogramming of Metabolic SubstratesSkeletal muscle mitochondrial uncoupling prevents diabetes but not obesity in NZO mice, a model for polygenic diabesity.Deletion of glucose transporter GLUT8 in mice increases locomotor activityImpaired leptin activity in New Zealand Obese mice: model of angiogenesis.Characterization of Nob3, a major quantitative trait locus for obesity and hyperglycemia on mouse chromosome 1.Early hypermethylation of hepatic Igfbp2 results in its reduced expression preceding fatty liver in mice.Lower core body temperature and greater body fat are components of a human thrifty phenotype.Loss of function of Ifi202b by a microdeletion on chromosome 1 of C57BL/6J mice suppresses 11β-hydroxysteroid dehydrogenase type 1 expression and development of obesity.Body temperature as a mouse pharmacodynamic response to bombesin receptor subtype-3 agonists and other potential obesity treatments.Neuronal functions, feeding behavior, and energy balance in Slc2a3+/- mice.Paclitaxel-induced hypothermia and hypoperfusion increase breast cancer metastasis and angiogenesis in mice.Characterization of a novel genetically obese mouse model demonstrating early onset hyperphagia and hyperleptinemia.Antiobesity and Hypolipidemic Activity of Moringa oleifera Leaves against High Fat Diet-Induced Obesity in Rats
P2860
Q27026287-52BB0127-29DB-48DF-9001-A7639B56ADD5Q27310317-B36FC869-6933-47E7-B2F8-1A571BCB225BQ28073389-79B6D411-83ED-4676-95BF-D8473179D37BQ30389400-857C9F43-4A39-48A5-8A62-97C5027D0CD2Q30420812-0BED593F-0F4B-47CA-9356-613C8B984D84Q30493853-A523F7A2-B208-4998-9084-6E03137280DDQ30498104-083959F1-BD21-4CFC-BAF5-E1CD7303ED1EQ33891770-12936103-7526-4F7D-9D08-80C0C0A50162Q33893305-E6C7CCBE-11C6-42C2-99BB-B0EF6B8399A3Q34125966-219B46A1-8A32-4B8E-BA9E-F854EF58330FQ34160509-6EAEEC04-6A50-4CFE-AAD7-64C17E23BD9FQ34185200-74B5C1B1-7F65-4776-972F-E707FA0A5769Q34497095-EBB22CA7-5EE8-4D9E-915D-8763AC6D9E47Q34513791-1C361775-81A8-4E59-8DE1-26C585BCBE21Q34597504-93C51E63-9AAF-4850-BA16-1913958B6014Q34793075-64821027-A4F3-47DE-970F-6096B8CFD40BQ35059492-0B6DA64D-4AAC-4B08-8236-23DDF36A1DC2Q35990442-422F2B0C-FDB0-4195-ADB5-92D02C5103AFQ36188924-BC5C6B82-3E70-488A-A5A0-DDF5FF8A49A4Q36300116-7507FFB8-BCCB-4D74-8927-AFCD6CC62376Q36785024-96A18F9F-035B-46BF-814E-794DD3411FF3Q36993797-54235F94-80A9-43CE-9244-68511CB5677EQ37265753-C6E4A2B1-0574-4DFB-AC00-E88A3FEFAB1BQ37530239-3E8635A7-AFF4-449B-8931-6C4D9380E6EDQ40395043-D3C950F9-3B92-4A67-99C8-625DB2ED9F50Q42833836-EAFD005C-B606-4368-959C-81A4BA221D27Q42921046-DC86675D-F658-415F-8FAC-11162F45C274Q45931773-E9E3E9A6-C44D-4C3D-B7C0-3BA758533871Q49752195-1341C1CC-78C6-4F7E-A4D5-CE7DDE01E625Q50937095-72DBD1F6-36FD-435F-B969-6053DB1E10A3Q59042570-2C7D929F-F2FA-43EA-B275-48ED78325796
P2860
Hyperphagia, lower body temperature, and reduced running wheel activity precede development of morbid obesity in New Zealand obese mice.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Hyperphagia, lower body temper ...... ity in New Zealand obese mice.
@en
Hyperphagia, lower body temper ...... ity in New Zealand obese mice.
@nl
type
label
Hyperphagia, lower body temper ...... ity in New Zealand obese mice.
@en
Hyperphagia, lower body temper ...... ity in New Zealand obese mice.
@nl
prefLabel
Hyperphagia, lower body temper ...... ity in New Zealand obese mice.
@en
Hyperphagia, lower body temper ...... ity in New Zealand obese mice.
@nl
P2093
P2860
P50
P1476
Hyperphagia, lower body temper ...... ity in New Zealand obese mice.
@en
P2093
Annette Schürmann
Hella S Jürgens
Reinhart Kluge
Sylvia Ortmann
P2860
P304
P356
10.1152/PHYSIOLGENOMICS.00252.2005
P577
2006-04-01T00:00:00Z